VOYA Investment Management
KNSA icon

VOYA Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

VOYA Investment Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$517K Buy
+8,077
New +$419K ﹤0.01% 1807
2026
Q1 		– Sell
-5,790
Closed -$239K – 2401
2025
Q4 		$239K Sell
5,790
-2,075
-26% -$83.2K ﹤0.01% 2079
2025
Q3 		$305K Sell
7,865
-12,191
-61% -$396K ﹤0.01% 1981
2025
Q2 		$555K Sell
20,056
-10,810
-35% -$275K ﹤0.01% 1846
2025
Q1 		$686K Buy
30,866
+10,878
+54% +$224K ﹤0.01% 1726
2024
Q4 		$395K Buy
19,988
+2,870
+17% +$65.5K ﹤0.01% 2049
2024
Q3 		$428K Buy
17,118
+4,344
+34% +$106K ﹤0.01% 2085
2024
Q2 		$238K Buy
12,774
+2,199
+21% +$41.2K ﹤0.01% 2380
2024
Q1 		$209K Sell
10,575
-2,183
-17% -$42.6K ﹤0.01% 2432
2023
Q4 		$224K Sell
12,758
-372
-3% -$6.11K ﹤0.01% 2526
2023
Q3 		$228K Hold
13,130
– – ﹤0.01% 2472
2023
Q2 		$185K Buy
13,130
+289
+2% +$3.87K ﹤0.01% 2618
2023
Q1 		$138K Sell
12,841
-8,600
-40% -$113K ﹤0.01% 2642
2022
Q4 		$321K Sell
21,441
-2,609
-11% -$38K ﹤0.01% 2290
2022
Q3 		$309K Buy
24,050
+12,122
+102% +$138K ﹤0.01% 2328
2022
Q2 		$116K Hold
11,928
– – ﹤0.01% 2579
2022
Q1 		$119K Hold
11,928
– – ﹤0.01% 2489
2021
Q4 		$140K Buy
11,928
+100
+0.8% +$1.23K ﹤0.01% 2606
2021
Q3 		$135K Hold
11,828
– – ﹤0.01% 2673
2021
Q2 		$165K Sell
11,828
-136
-1% -$2.07K ﹤0.01% 2658
2021
Q1 		$221K Buy
11,964
+581
+5% +$11.9K ﹤0.01% 2487
2020
Q4 		$201K Buy
+11,383
New +$200K ﹤0.01% 2423

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

VOYA Investment Management's KNSA Position: Q2 2026 in Review

VOYA Investment Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 8,077 shares worth $517K. The stake represents ﹤0.01% of the portfolio and ranks #1807 among its holdings. This is a return to the name: VOYA Investment Management previously reported a position in KNSA as recently as Q4 2025.

VOYA Investment Management first reported a position in KNSA in Q4 2020 and has held it in 22 quarters since. The position peaked at $686K in Q1 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • VOYA Investment Management held 8,077 shares of Kiniksa Pharmaceuticals worth $517K as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new VOYA Investment Management position in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1807 holding.
  • VOYA Investment Management first reported a position in Kiniksa Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • VOYA Investment Management's Kiniksa Pharmaceuticals position peaked at $686K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.